Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IS-002 in Robotic-Assisted Radical Prostatectomy
NCT05946603Phase 2Completed
- Sponsor
- Intuitive Surgical
- Start
- Jun 2023
- Primary completion
- May 2024
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of sonzivotide filricianine in prostate cancer (PCa), sponsored by Intuitive Surgical. Started Jun 2023; status: completed.
02
Drugs
sonzivotide filricianine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05946603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05946603.